SA pharmacy reforms 'create rural shortage'

16 July 2006

Rural South African pharmacies are being forced out of business as the result of reforms designed to make drugs more affordable for the country's poorest communities. An unintended consequence of the government's price intervention has been to deprive many people of local access to over-the-counter drugs, forcing them to pay consultation fees to doctors who then dispense the drug or travel to sometimes distant towns.

Steinsburg, an Eastern Cape provincial town with a population of 16,000, lost its only pharmacy recently, suggesting that competition from new larger firms is not always as significant a factor as local commentators report.

Price reductions, which could save up to 3.0 billion rand ($422.1 million) per year, however, enjoy popular support in South Africa, where an estimated five million people are infected with HIV/AIDS, the second largest number after India (Marketletter June 12). Many sufferers are not covered by medical insurers.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight